Your browser doesn't support javascript.
loading
Liver elastography for risk-assessment of liver toxicity and risk factors for Sinusoidal obstruction syndrome in patients with acute lymphoblastic leukemia receiving inotuzumab ozogamicin.
Senapati, Jayastu; Jabbour, Elias; Short, Nicholas J; Jain, Nitin; Haddad, Fadi; Bathala, Tharakeswara; Kovalenko, Iuliia; Bidikian, Aram; Ravandi, Farhad; Khouri, Issa; Kadia, Tapan M; Garris, Rebecca; Montalban Bravo, Guillermo; Chien, Kelly; Shpall, Elizabeth; Kebriaei, Partow; Kantarjian, Hagop M.
Afiliação
  • Senapati J; Department of Leukemia, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA.
  • Jabbour E; Department of Leukemia, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA. ejabbour@mdanderson.org.
  • Short NJ; Department of Leukemia, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA.
  • Jain N; Department of Leukemia, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA.
  • Haddad F; Department of Leukemia, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA.
  • Bathala T; Department of Abdominal Imaging, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA.
  • Kovalenko I; Department of Leukemia, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA.
  • Bidikian A; Department of Medicine, University of Pittsburgh Medical Center Harrisburg, Harrisburg, PA, USA.
  • Ravandi F; Department of Leukemia, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA.
  • Khouri I; Department of Leukemia, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA.
  • Kadia TM; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA.
  • Garris R; Department of Leukemia, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA.
  • Montalban Bravo G; Department of Leukemia, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA.
  • Chien K; Department of Leukemia, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA.
  • Shpall E; Department of Leukemia, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA.
  • Kebriaei P; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA.
  • Kantarjian HM; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA.
Blood Cancer J ; 14(1): 129, 2024 Aug 07.
Article em En | MEDLINE | ID: mdl-39112504

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hepatopatia Veno-Oclusiva / Leucemia-Linfoma Linfoblástico de Células Precursoras / Técnicas de Imagem por Elasticidade / Inotuzumab Ozogamicina Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hepatopatia Veno-Oclusiva / Leucemia-Linfoma Linfoblástico de Células Precursoras / Técnicas de Imagem por Elasticidade / Inotuzumab Ozogamicina Idioma: En Ano de publicação: 2024 Tipo de documento: Article